Clinical trial
Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
NCT00061516 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
- Lead sponsor
- Alcon Research
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- February 28, 2006
- Enrollment
- 78 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.